
William G. Wright
Examiner (ID: 13821)
| Most Active Art Unit | 1106 |
| Art Unit(s) | 1106, 1754 |
| Total Applications | 637 |
| Issued Applications | 554 |
| Pending Applications | 0 |
| Abandoned Applications | 83 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11857864
[patent_doc_number] => 09737531
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-08-22
[patent_title] => 'Composition and method for treatment of depression and psychosis in humans'
[patent_app_type] => utility
[patent_app_number] => 13/936198
[patent_app_country] => US
[patent_app_date] => 2013-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 8925
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 146
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13936198
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/936198 | Composition and method for treatment of depression and psychosis in humans | Jul 6, 2013 | Issued |
Array
(
[id] => 10975383
[patent_doc_number] => 20140378419
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-12-25
[patent_title] => 'Compositions and Methods for Nutrient Delivery'
[patent_app_type] => utility
[patent_app_number] => 13/923526
[patent_app_country] => US
[patent_app_date] => 2013-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6595
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13923526
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/923526 | Compositions and Methods for Nutrient Delivery | Jun 20, 2013 | Abandoned |
Array
(
[id] => 9198918
[patent_doc_number] => 20130338233
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-19
[patent_title] => 'METHODS FOR MICROBIAL BIOFILM DESTRUCTION'
[patent_app_type] => utility
[patent_app_number] => 13/921916
[patent_app_country] => US
[patent_app_date] => 2013-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8019
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13921916
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/921916 | Methods for microbial biofilm destruction | Jun 18, 2013 | Issued |
Array
(
[id] => 9108580
[patent_doc_number] => 20130281712
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-24
[patent_title] => 'Dosage Regimen of an S1P Receptor Agonist'
[patent_app_type] => utility
[patent_app_number] => 13/920406
[patent_app_country] => US
[patent_app_date] => 2013-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9513
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13920406
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/920406 | Dosage Regimen of an S1P Receptor Agonist | Jun 17, 2013 | Abandoned |
Array
(
[id] => 9263259
[patent_doc_number] => 20130345188
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-26
[patent_title] => 'Preparation and Uses of Obeticholic Acid'
[patent_app_type] => utility
[patent_app_number] => 13/919734
[patent_app_country] => US
[patent_app_date] => 2013-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 48
[patent_figures_cnt] => 48
[patent_no_of_words] => 34951
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13919734
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/919734 | Preparation and uses of obeticholic acid | Jun 16, 2013 | Issued |
Array
(
[id] => 9198805
[patent_doc_number] => 20130338120
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-19
[patent_title] => 'Aspirin Derivatives and Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 13/918394
[patent_app_country] => US
[patent_app_date] => 2013-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 28641
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13918394
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/918394 | Aspirin derivatives and uses thereof | Jun 13, 2013 | Issued |
Array
(
[id] => 9192079
[patent_doc_number] => 20130331394
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-12
[patent_title] => 'TREATING SCHIZOPHRENIA'
[patent_app_type] => utility
[patent_app_number] => 13/915413
[patent_app_country] => US
[patent_app_date] => 2013-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 16498
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13915413
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/915413 | TREATING SCHIZOPHRENIA | Jun 10, 2013 | Abandoned |
Array
(
[id] => 9511984
[patent_doc_number] => 20140148476
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-29
[patent_title] => 'METHODS FOR TREATING OBESITY AND DISORDERS ASSOCIATED WITH HYPERLIPIDEMIA IN A MAMMAL'
[patent_app_type] => utility
[patent_app_number] => 13/911544
[patent_app_country] => US
[patent_app_date] => 2013-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6485
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13911544
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/911544 | METHODS FOR TREATING OBESITY AND DISORDERS ASSOCIATED WITH HYPERLIPIDEMIA IN A MAMMAL | Jun 5, 2013 | Abandoned |
Array
(
[id] => 9082019
[patent_doc_number] => 20130267549
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-10
[patent_title] => 'Use of Pyrimidylaminobenzamide Derivatives for the Treatment of Fibrosis'
[patent_app_type] => utility
[patent_app_number] => 13/911127
[patent_app_country] => US
[patent_app_date] => 2013-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5147
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13911127
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/911127 | Use of Pyrimidylaminobenzamide Derivatives for the Treatment of Fibrosis | Jun 5, 2013 | Abandoned |
Array
(
[id] => 10945766
[patent_doc_number] => 20140348787
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-11-27
[patent_title] => 'Methods and Compositions for Treating Ear Infections'
[patent_app_type] => utility
[patent_app_number] => 13/900323
[patent_app_country] => US
[patent_app_date] => 2013-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 2538
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13900323
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/900323 | Methods and Compositions for Treating Ear Infections | May 21, 2013 | Abandoned |
Array
(
[id] => 9597711
[patent_doc_number] => 20140194392
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-10
[patent_title] => 'DRUG SCREENING METHOD'
[patent_app_type] => utility
[patent_app_number] => 13/872456
[patent_app_country] => US
[patent_app_date] => 2013-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11820
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13872456
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/872456 | DRUG SCREENING METHOD | Apr 28, 2013 | Abandoned |
Array
(
[id] => 9293914
[patent_doc_number] => 20140037548
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-06
[patent_title] => 'Treatment and prevention of diffuse parenchymal lung disease by selective active-site mTOR inhibitors'
[patent_app_type] => utility
[patent_app_number] => 13/867123
[patent_app_country] => US
[patent_app_date] => 2013-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 43
[patent_figures_cnt] => 43
[patent_no_of_words] => 15554
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13867123
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/867123 | Treatment and prevention of diffuse parenchymal lung disease by selective active-site mTOR inhibitors | Apr 20, 2013 | Abandoned |
Array
(
[id] => 9910270
[patent_doc_number] => 20150065472
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-05
[patent_title] => 'INTRAUTERINE APPLICATION OF 18-METHYL-15SS,16SS-METHYLENE-19-NOR-20-SPIROX-4-EN-3-ONE SYSTEMS, INTRAUTERINE SYSTEMS CONTAINING 18-METHYL-15SS,16SS-METHYLENE-19-NOR-20-SPIROX-4-EN-3-ONE, AS WELL AS THE USE THEREOF IN CONTRACEPTION AND GYNAECOLOGICAL THERAPY'
[patent_app_type] => utility
[patent_app_number] => 14/396736
[patent_app_country] => US
[patent_app_date] => 2013-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 3339
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14396736
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/396736 | INTRAUTERINE APPLICATION OF 18-METHYL-15SS,16SS-METHYLENE-19-NOR-20-SPIROX-4-EN-3-ONE SYSTEMS, INTRAUTERINE SYSTEMS CONTAINING 18-METHYL-15SS,16SS-METHYLENE-19-NOR-20-SPIROX-4-EN-3-ONE, AS WELL AS THE USE THEREOF IN CONTRACEPTION AND GYNAECOLOGICAL THERAPY | Apr 18, 2013 | Abandoned |
| 13/857583 | REVERSAL OF HIGH BREAST CANCER RISK IN MAMMALS EXPOSED TO ESTROGENIC CHEMICALS IN UTERO BY ADULT EXPOSURE TO HDAC AND DNMT INHIBITORS | Apr 4, 2013 | Abandoned |
Array
(
[id] => 10241537
[patent_doc_number] => 20150126533
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-07
[patent_title] => 'ADMINISTRATION OF A RAF INHIBITOR AND A MEK INHIBITOR IN THE TREATMENT OF MELANOMA'
[patent_app_type] => utility
[patent_app_number] => 14/389515
[patent_app_country] => US
[patent_app_date] => 2013-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 5134
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14389515
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/389515 | ADMINISTRATION OF A RAF INHIBITOR AND A MEK INHIBITOR IN THE TREATMENT OF MELANOMA | Mar 28, 2013 | Abandoned |
Array
(
[id] => 9004485
[patent_doc_number] => 20130225610
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-29
[patent_title] => 'ANTIMETASTATIC COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 13/846421
[patent_app_country] => US
[patent_app_date] => 2013-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14368
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13846421
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/846421 | ANTIMETASTATIC COMPOUNDS | Mar 17, 2013 | Abandoned |
Array
(
[id] => 18171800
[patent_doc_number] => 11571493
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-07
[patent_title] => Co-precipitation method
[patent_app_type] => utility
[patent_app_number] => 14/384130
[patent_app_country] => US
[patent_app_date] => 2013-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 2
[patent_no_of_words] => 8146
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 466
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14384130
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/384130 | Co-precipitation method | Mar 14, 2013 | Issued |
Array
(
[id] => 8990599
[patent_doc_number] => 20130217880
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-22
[patent_title] => 'PURINONE DERIVATIVE'
[patent_app_type] => utility
[patent_app_number] => 13/833520
[patent_app_country] => US
[patent_app_date] => 2013-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25006
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13833520
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/833520 | Purinone derivative | Mar 14, 2013 | Issued |
Array
(
[id] => 10248437
[patent_doc_number] => 20150133434
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-14
[patent_title] => 'Compositions and Methods for Reactivating Latent Immunodeficiency Virus'
[patent_app_type] => utility
[patent_app_number] => 14/385475
[patent_app_country] => US
[patent_app_date] => 2013-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 42
[patent_figures_cnt] => 42
[patent_no_of_words] => 26696
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14385475
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/385475 | Compositions and Methods for Reactivating Latent Immunodeficiency Virus | Mar 12, 2013 | Abandoned |
Array
(
[id] => 9857419
[patent_doc_number] => 20150037437
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-02-05
[patent_title] => 'GLIOMA TREATMENT'
[patent_app_type] => utility
[patent_app_number] => 14/379358
[patent_app_country] => US
[patent_app_date] => 2013-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 12773
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14379358
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/379358 | GLIOMA TREATMENT | Mar 11, 2013 | Abandoned |